Godelieve Verplancke
Director/Board Member at MATERIALISE NV
Net worth: - $ as of 30/05/2024
Godelieve Verplancke active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MATERIALISE NV | Director/Board Member | 08/06/2015 | - |
| Independent Dir/Board Member | 08/06/2015 | - | |
| MDXHEALTH SA | Director/Board Member | 25/05/2017 | - |
| Independent Dir/Board Member | 25/05/2017 | - | |
| Fondation contre le Cancer | Director/Board Member | - | - |
Career history of Godelieve Verplancke
Former positions of Godelieve Verplancke
| Companies | Position | Start | End |
|---|---|---|---|
| Qaly-Co BV | Founder | 31/12/2012 | 31/12/2019 |
| Corporate Officer/Principal | 31/12/2012 | 31/12/2019 | |
| Qaly | Chief Executive Officer | 31/12/2012 | 31/12/2019 |
| Founder | 31/12/2012 | 31/12/2019 | |
Bristol-Myers Squibb Belgium SA
 Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Corporate Officer/Principal | - | 31/12/2011 |
| Stichting Tegen Kanker | Director/Board Member | - | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
| Imelda Hospital | Director/Board Member | - | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Godelieve Verplancke
| University of Antwerp | Graduate Degree |
| Katholieke Universiteit Leuven | Doctorate Degree |
Statistics
International
| Belgium | 13 |
| United States | 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MATERIALISE NV | Technology Services |
| MDXHEALTH SA | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private companies | 8 |
|---|---|
| Qaly | |
Bristol-Myers Squibb Belgium SA
Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Health Technology |
Quest for Growth NV
 Quest for Growth NV Investment ManagersFinance Quest for Growth NV, a fund traded on Euronext Brussels, has a diversified portfolio which is invested in growth companies listed on European stock exchanges, in European unquoted companies and in venture capital funds. It targets companies operating in the fields of healthcare, healthy living, well-being, human development, smart industries, digitalisation and clean technology & sustainable chemistry. It provides financing for growth stage capital requirements. It also makes co-investments. | Finance |
Euronext Brussels SA/NV
 Euronext Brussels SA/NV Investment Banks/BrokersFinance Euronext Brussels SA/NV operates a stock exchange. It provides services for regulated stock and derivatives markets in Belgium. The company also offers services, such as facilitating public offerings, providing trading facilities for cash & derivatives products and supplying market data. Euronext Brussels was founded in 1801 and is headquartered in Brussels, Belgium. | Finance |
| Imelda Hospital | |
| Qaly-Co BV | |
| Stichting Tegen Kanker | Miscellaneous |
| Fondation contre le Cancer | Miscellaneous |
- Stock Market
- Insiders
- Godelieve Verplancke
- Experience
